biomedical research

Dear Research Advocate, With all the conversation about the debt ceiling and tax and entitlement reform, it may surprise you to know that an additional topic is on many minds. A wide majority of Americans, 72%, say the new Congress and the president should take action to expand medical research within the first 100 days of the new legislative session. See this and more in America Speaks , Volume 13, a compilation of national poll data providing insights into public sentiment on key research-related issues. See our press release and download the full Poll Data Summary . These polling results are designed to be used in your advocacy and outreach! Among the growing number of issues that need...
New Poll Data Summary reveals concerns among Americans about medical progress even in tight fiscal environment Alexandria, Va. - January 9, 2013 - America Speaks , Volume 13, a compilation of public opinion polls commissioned by Research!America, features timely data about Americans’ views on issues related to biomedical and health research. A majority of Americans (72%) say the new Congress and the President should take action to expand medical research within the first 100 days of the 113 th Congress. Public support for increased government spending on medical research holds particular relevance as Congress considers whether to further delay, eliminate or permit “sequestration,” a budget...
Dear Research Advocate, Congress is back and there is talk of more stalemate, with support wavering for a deal to avert the fiscal cliff before the end of the year. Speaker John Boehner said early today that ’€œno substantive progress has been made’€ on negotiations. Amazingly, inaction (going over the cliff) remains a possibility. The more likely scenario is a short-term fix that leaves the major decisions in the hands of the next Congress. In the midst of behind-the-scenes negotiations between congressional leadership and the White House, appropriators are talking about finalizing their bills before the end of the lame-duck session rather than waiting to revisit the current continuing...
Dear Research Advocate, With a stellar team of advocates from across the research community, we have been blitzing Capitol Hill this week with our message that we need cures, not cuts. Research!America and our partners have participated in more than 60 meetings with Members of Congress, including key leadership and their staff. My thanks to the 140+ groups that signed on to our community letter to congressional leadership. Many partners have activated their grassroots to join the call Congress day, and there is still time to join the In-District Drop-In day (today) and a social media push on Friday. We also encourage you to keep up the drumbeat with emails and phone calls to Hill offices...
Research, Industry, Academic and Patient Groups Join Forces for Week of Advocacy to Save Research, November 12-16, 2012 WASHINGTON ’€“ November 1, 2012 ’€“ Research!America, along with several dozen patient, industry, academic and health organizations, has coordinated a Week of Advocacy to Save Research for the week of November 12-16, 2012. The unified campaign is intended to convince policy makers to champion medical innovation, rather than undercut it, as decisions are made to address the ’€œfiscal cliff.’€ The campaign ’€” We Need Cures, Not Cuts ’€”is designed to raise awareness about the importance of making biomedical and health research a higher national priority. The campaign will...
Dear Research Advocate, Sandy was a terrifying October surprise. The devastation in New York and New Jersey is extensive, and it will take a long time to rebuild and to heal. It’€™s a reminder that not everything is about the election. That said, it is impossible not to think about a major election theme ’€” the role of government ’€” and also to think about climate change, one of many science topics not being discussed in this election season. Yet decisions involving the future of science will be made by those elected. That’€™s why we need to turn up the advocacy volume as loud as possible after the election, when the lame-duck Congress and the administration, closely watched and...
Pending Budget Cuts will Further Jeopardize Global Leadership in Research and Innovation WASHINGTON, DC ’€”October 25, 2012’€”Biomedical and health research and development (R&D) spending from all sources declined by more than $4 billion or 3% between FY10 and FY11 according to Research!America’€™s 2011 U.S. Investment in Health Research report. This represents the first drop in overall spending since Research!America began compiling the data in 2002. The decline follows an uptick in research funding attributed to the American Recovery and Reinvestment Act (ARRA), which allocated $10.4 billion to the National Institutes of Health (NIH) over two fiscal years (2009-2010). The overall...
Dear Research Advocate, As you know, the Republican Party Platform was unveiled Tuesday during the convention in Tampa. There are direct references to medical and health research and other statements that ’€” if not explicit ’€” definitely imply the need for such research. We can draw from both to enhance our advocacy efforts. The following exemplifies the direct and indirect nature of the platform’€™s embrace of medical and health research: ’€œWe support federal investment in health care delivery systems and solutions creating innovative means to provide greater, more cost-effective access to high quality health care. We also support federal investment in basic and applied biomedical...

Pages

Sidebar Quote

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco